232
Views
22
CrossRef citations to date
0
Altmetric
Review

Muscle function in COPD: a complex interplay

, , , &
Pages 523-535 | Published online: 17 Aug 2012

References

  • LopezADMurrayCCThe global burden of disease, 1990–2020Nat Med1998411124112439809543
  • ManWDKempPMoxhamJPolkeyMISkeletal muscle dysfunction in COPD: clinical and laboratory observationsClin Sci (Lond)2009117725126419681758
  • GosselinkRTroostersTDecramerMPeripheral muscle weakness contributes to exercise limitation in COPDAm J Respir Crit Care Med199615339769808630582
  • SimpsonKKillianKMcCartneyNStubbingDGJonesNLRandomised controlled trial of weightlifting exercise in patients with chronic airflow limitationThorax199247270751549826
  • DecramerMGosselinkRTroostersTVerschuerenMEversGMuscle weakness is related to utilization of health care resources in COPD patientsEur Respir J19971024174239042643
  • SwallowEBReyesDHopkinsonNSQuadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary diseaseThorax200762211512017090575
  • ManWMustfaNNikoletouDEffect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPDThorax200459647147615170026
  • Gray-DonaldKGibbonsLShapiroSHMacklemPTMartinJGNutritional status and mortality in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199615339619668630580
  • BernardSLeBlancPWhittomFPeripheral muscle weakness in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199815826296349700144
  • ManWDHopkinsonNSHarrafFNikoletouDPolkeyMIMoxhamJAbdominal muscle and quadriceps strength in chronic obstructive pulmonary diseaseThorax200560971872215923239
  • ManWSolimanMNikoletouDNon-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary diseaseThorax200358866566912885979
  • AllaireJMaltaisFDoyonJFPeripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPDThorax200459867367815282387
  • ManWDSolimanMGGearingJSymptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2003168556256712829456
  • MadorMJDenizOAggarwalAKufelTJQuadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2003168110210812689846
  • CoronellCOrozco-LeviMMendezRRamirez-SarmientoAGáldizJBGeaJRelevance of assessing quadriceps endurance in patients with COPDEur Respir J200424112913615293615
  • MathurSTakaiKPMacintyreDLReidDEstimation of thigh muscle mass with magnetic resonance imaging in older adults and people with chronic obstructive pulmonary diseasePhys Ther200888221923018056754
  • SeymourJMWardKSidhuPSUltrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPDThorax200964541842319158125
  • MarquisKDebigaréRLacasseYMidthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2002166680981312231489
  • GoskerHREngelenMPvan MamerenHMuscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary diseaseAm J Clin Nutr200276111311912081824
  • GoskerHRZeegersMPWoutersEFScholsAMMuscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysisThorax2007621194494917526675
  • WhittomFJobinJSimardPMHistochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary diseaseMed Sci Sports Exerc19983010146714749789845
  • JobinJMaltaisFDoyonJFChronic obstructive pulmonary disease: capillarity and fiber type characteristics of skeletal muscleJ Cardiopulm Rehabil19981864324379857275
  • MaltaisFSimardAASimardCJobinJDesgagnésPLeBlancPOxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPDAm J Respir Crit Care Med199615312882938542131
  • JakobssonPJorfeldtLHenrikssonJMetabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19951512 Pt 13743777842194
  • KutsuzawaTShioyaSKuritaDHaidaMOhtaYYamabayashiHMuscle energy metabolism and nutritional status in patients with chronic obstructive pulmonary disease. A 31P magnetic resonance studyAm J Respir Crit Care Med199515226476527633721
  • MaltaisFJobinJSullivanMJMetabolic and hemodynamic responses of lower limb during exercise in patients with COPDJ Appl Physiol1998845157315809572801
  • SwallowEBGoskerHRWardKAA novel technique for nonvolitional assessment of quadriceps muscle endurance in humansJ Appl Physiol2007103373974617569771
  • NewellSZMcKenzieDKGandeviaSCInspiratory and skeletal muscle strength and endurance and diaphragmatic activation in patients with chronic airflow limitationThorax198944119039122595630
  • GeaJGPastoMCarmonaMAOrozco-LeviMPalomequeJBroquetasJMetabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary diseaseEur Respir J200117593994511488330
  • SatoYAsohTHondaYFujimatsuYHiguchiIOizumiKMorphologic and histochemical evaluation of muscle in patients with chronic pulmonary emphysema manifesting generalized emaciationEur Neurol19973721161219058068
  • SimilowskiTYanSGauthierAPMacklemPTBellemareFContractile properties of the human diaphragm during chronic hyperinflationN Engl J Med1991325139179231881417
  • LevineSKaiserLLeferovichJTikunovBCellular adaptations in the diaphragm in chronic obstructive pulmonary diseaseN Engl J Med199733725179918069400036
  • MercadierJJSchwartzKSchiaffinoSMyosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflationAm J Physiol19982744 Pt 1L5275349575870
  • DoucetMDebigaréRJoanisseDRAdaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPDEur Respir J200424697197915572541
  • OttenheijmCAHeunksLMSieckGCDiaphragm dysfunction in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005172220020515849324
  • StubbingsAKMooreAJDusmetMPhysiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary diseaseJ Physiol2008586Pt 102637265018372305
  • LevineSNguyenTKaiserLRHuman diaphragm remodeling associated with chronic obstructive pulmonary disease: clinical implicationsAm J Respir Crit Care Med2003168670671312857719
  • Orozco-LeviMGeaJLloretaJLSubcellular adaptation of the human diaphragm in chronic obstructive pulmonary diseaseEur Respir J199913237137810065684
  • LevineSGregoryCNguyenTBioenergetic adaptation of individual human diaphragmatic myofibers to severe COPDJ Appl Physiol20029231205121311842060
  • PolkeyMIKyroussisDHamnegardCHDiaphragm performance during maximal voluntary ventilation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199715526426489032207
  • PolkeyMIKyroussisDKeiltySEExhaustive treadmill exercise does not reduce twitch transdiaphragmatic pressure in patients with COPDAm J Respir Crit Care Med199515239599647663810
  • LevineSNguyenTFrisciaMParasternal intercostal muscle remodeling in severe chronic obstructive pulmonary diseaseJ Appl Physiol200610151297130216777998
  • GeaJOrozco-LeviMAguarMCAdaptive changes concerning the types of fibres and isoforms of myosin in the external intercostal muscle of COPD patientsEur Respir J19969160S
  • SeymourJMSpruitMAHopkinsonNSThe prevalence of quadriceps weakness in COPD and the relationship with disease severityEur Respir J2010361818819897554
  • SerresIGautierVVarrayAPréfautCImpaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patientsChest199811349009059554623
  • GoskerHRKubatBSchaartGvan der VusseGJWoutersEFScholsAMMyopathological features in skeletal muscle of patients with chronic obstructive pulmonary diseaseEur Respir J200322228028512952261
  • DegensHSanchez HornerosJMHeijdraYFDekhuijzenPNHopmanMTSkeletal muscle contractility is preserved in COPD patients with normal fat-free massActa Physiol Scand2005184323524215954991
  • OttenheijmCAHeunksLMDekhuijzenRPDiaphragm adaptations in patients with COPDRespir Res2008911218218129
  • van den BorstBKosterAYuBIs age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking?Thorax2011661196196921724748
  • WatzHWaschkiBMeyerTMagnussenHPhysical activity in patients with COPDEur Respir J200933226227219010994
  • KonSSManWDMuscle mass and strength in obstructive lung disease: a smoking gun?Thorax2011661193393521813620
  • PolkeyMIMoxhamJAttacking the disease spiral in chronic obstructive pulmonary diseaseClin Med20066219019616688981
  • BossenbroekLde GreefMHWempeJBKrijnenWPTen HackenNHDaily physical activity in patients with chronic obstructive pulmonary disease: a systematic reviewCOPD20118430631921728804
  • DecramerMRennardSTroostersTCOPD as a lung disease with systemic consequences – clinical impact, mechanisms, and potential for early interventionCOPD20085423525618671149
  • PittaFTroostersTSpruitMAProbstVSDecramerMGosselinkRCharacteristics of physical activities in daily life in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171997297715665324
  • GoskerHRLencerNHFranssenFMvan der VusseGJWoutersEFScholsAMStriking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPDChest200312351416142412740256
  • SpruitMGosselinkRTroostersTMuscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-IThorax200358975275612947130
  • SeymourJMMooreLJolleyCJOutpatient pulmonary rehabilitation following acute exacerbations of COPDThorax201065542342820435864
  • TroostersTProbstVSCrulTResistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2010181101072107720133927
  • Garcia-AymerichJFarreroEFélezMAIzquierdoJMarradesRMAntóJMEstudi del Factors de Risc d’Agudització de la MPOC investigatorsRisk factors of readmission to hospital for a COPD exacerbation: a prospective studyThorax200358210010512554887
  • Garcia-AymerichJLangePBenetMSchnohrPAntoJMRegular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort studyThorax200661977277816738033
  • Garcia-AymerichJLangePBenetMSchnohrPAntóJMRegular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort studyAm J Respir Crit Care Med2007175545846317158282
  • YendeSWatererGWTolleyEAInflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjectsThorax2006611101616284220
  • DebigaréRMarquisKCôtéCHCatabolic/anabolic balance and muscle wasting in patients with COPDChest20031241838912853506
  • EidAAIonescuAANixonLSInflammatory response and body composition in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20011648 Pt 11414141811704588
  • WagnerPDPossible mechanisms underlying the development of cachexia in COPDEur Respir J200831349250118310396
  • BarreiroEScholsAMPolkeyMIENIGMA in COPD projectCytokine profile in quadriceps muscles of patients with severe COPDThorax200863210010717875568
  • PetersenAMPenkowaMIversenMElevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary diseaseLung2007185316117117436040
  • CrulTSpruitMAGayan-RamirezGMarkers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patientsEur J Clin Invest2007371189790417883420
  • KoechlinCCouillardASimarDDoes oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?Am J Respir Crit Care Med200416991022102715001462
  • ReidMBNitric oxide, reactive oxygen species, and skeletal muscle contractionMed Sci Sports Exerc200133337137611252061
  • BarreiroEde la PuenteBMinguellaJOxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171101116112415735057
  • SupinskiGSCallahanLAFree radical-mediated skeletal muscle dysfunction in inflammatory conditionsJ Appl Physiol200710252056206317218425
  • BarreiroERabinovichRMarin-CorralJBarberàJAGeaJRocaJChronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPDThorax2009641131918835959
  • GoskerHRBastAHaenenGRAltered antioxidant status in peripheral skeletal muscle of patients with COPDRespir Med200599111812515672860
  • CouillardAMaltaisFSaeyDExercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2003167121664166912672647
  • BarreiroEGeaJCorominasJMHussainSNNitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol200329677177812816735
  • CouillardAKoechlinCCristolJPVarrayAPrefautCEvidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patientsEur Respir J20022051123112912449164
  • HopkinsonNSNickolAHPayneJAngiotensin converting enzyme genotype and strength in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2004170439539915117739
  • HopkinsonNSEleftheriouKIPayneJ+9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary diseaseAm J Clin Nutr200683491291716600946
  • HopkinsonNSLiKWKehoeAVitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary diseaseAm J Clin Nutr200887238539018258629
  • BroekhuizenRGrimbleRFHowellWMPulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta-511 single nucleotide polymorphismAm J Clin Nutr20058251059106416280439
  • EngelenMPScholsAMBakenWCWesselingGJWoutersEFNutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPDEur Respir J1994710179317977828687
  • FerreiraIMBrooksDLacasseYGoldsteinRSNutritional support for individuals with COPD: a meta-analysisChest2000117367267810712990
  • Op den KampCMLangenRCHaegensAScholsAMMuscle atrophy in cachexia: can dietary protein tip the balance?Curr Opin Clin Nutr Metab Care200912661161619741519
  • BurdetLde MuraltBSchutzYPichardCFittingJWAdministration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled studyAm J Respir Crit Care Med19971566180018069412558
  • CreutzbergECWoutersEFMostertRPluymersRJScholsAMA role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trialChest200312451733174214605042
  • CasaburiRBhasinSCosentinoLEffects of testosterone and resistance training in men with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2004170887087815271690
  • ScholsAMPulmonary cachexiaInt J Cardiol200285110111012163214
  • DecramerMLacquetLMFagardRRogiersPCorticosteroids contribute to muscle weakness in chronic airflow obstructionAm J Respir Crit Care Med1994150111168025735
  • HopkinsonNSManWDDayerMJAcute effect of oral steroids on muscle function in chronic obstructive pulmonary diseaseEur Respir J200424113714215293616
  • NaderGAMolecular determinants of skeletal muscle mass: getting the “AKT” togetherInt J Biochem Cell Biol200537101985199616125108
  • RommelCBodineSCClarkeBAMediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathwaysNat Cell Biol20013111009101311715022
  • HaraKYonezawaKKozlowskiMTRegulation of eIF-4E BP1 phosphorylation by mTORJ Biol Chem19972724226457264639334222
  • CrossDAAlessiDRCohenPAndjelkovichMHemmingsBAInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature199537865597857898524413
  • SandriMSandriCGilbertAFoxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophyCell2004117339941215109499
  • BodineSCLatresEBaumhueterSIdentification of ubiquitin ligases required for skeletal muscle atrophyScience200129455471704170811679633
  • DoucetMRussellAPLégerBMuscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007176326126917478621
  • PlantPJBrooksDFaughnanMCellular markers of muscle atrophy in chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol201042446147119520920
  • RennieMJAnabolic resistance: the effects of aging, sexual dimorphism, and immobilization on human muscle protein turnoverAppl Physiol Nutr Metab200934337738119448702
  • de BoerMDSelbyAAthertonPThe temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuseJ Physiol2007585Pt 124125117901116
  • MarimuthuKMurtonAJGreenhaffPLMechanisms regulating muscle mass during disuse atrophy and rehabilitation in humansJ Appl Physiol2011110255556021030670
  • McPherronACLawlerAMLeeSJRegulation of skeletal muscle mass in mice by a new TGF-beta superfamily memberNature1997387662883909139826
  • McPherronACLeeSJDouble muscling in cattle due to mutations in the myostatin geneProc Natl Acad Sci U S A1997942312457124619356471
  • SchuelkeMWagnerKRStolzLEMyostatin mutation associated with gross muscle hypertrophy in a childN Engl J Med2004350262682268815215484
  • ThomasMLangleyBBerryCMyostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferationJ Biol Chem200027551402354024310976104
  • LangleyBThomasMBishopASharmaMGilmourSKambadurRMyostatin inhibits myoblast differentiation by down-regulating MyoD expressionJ Biol Chem200227751498314984012244043
  • McFarlaneCPlummerEThomasMMyostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB- independent, FoxO1-dependent mechanismJ Cell Physiol2006209250151416883577
  • McFarlaneCHennebryAThomasMMyostatin signals through Pax7 to regulate satellite cell self-renewalExp Cell Res2008314231732917949710
  • VogiatzisISimoesDCStratakosGEffect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPDEur Respir J201036230131020110400
  • LewisMIFournierMStorerTWSkeletal muscle adaptations to testosterone and resistance training in men with COPDJ Appl Physiol200710341299131017673568
  • D-C ManWNatanekSARiddoch-ContrerasJQuadriceps myostatin expression in COPDEur Respir J201036368668820930205
  • SchiaffinoSSandriMMurgiaMActivity-dependent signaling pathways controlling muscle diversity and plasticityPhysiology (Bethesda)20072226927817699880
  • WuHNayaFJMcKinseyTAMEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber typeEMBO J20001991963197310790363
  • NayaFJMercerBSheltonJRichardsonJAWilliamsRSOlsonENStimulation of slow skeletal muscle fiber gene expression by calcineurin in vivoJ Biol Chem200027574545454810671477
  • ChinEROlsonENRichardsonJAA calcineurin-dependent transcriptional pathway controls skeletal muscle fiber typeGenes Dev19981216249925099716403
  • LongYCGlundSGarcia-RovesPMZierathJRCalcineurin regulates skeletal muscle metabolism via coordinated changes in gene expressionJ Biol Chem200728231607161417107952
  • LuquetSLopez-SorianoJHolstDPeroxisome proliferator-activated receptor delta controls muscle development and oxidative capabilityFASEB J200317152299230114525942
  • BeckerJDelayre-OrthezCFrossardNPonsFRegulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?Fundam Clin Pharmacol200620542944716968414
  • LuquetSGaudelCHolstDRoles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetesBiochim Biophys Acta20051740231331715949697
  • WangYXZhangCLYuRTRegulation of muscle fiber type and running endurance by PPARdeltaPLoS Biol2004210e29415328533
  • MahoneyDJPariseGMelovSSafdarATarnopolskyMAAnalysis of global mRNA expression in human skeletal muscle during recovery from endurance exerciseFASEB J200519111498150015985525
  • PuigserverPSpiegelmanBMPeroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulatorEndocr Rev2003241789012588810
  • RemelsAHSchrauwenPBroekhuizenRPeroxisome proliferator- activated receptor expression is reduced in skeletal muscle in COPDEur Respir J200730224525217459894
  • RemelsAHGoskerHRSchrauwenPLangenRCScholsAMPeroxisome proliferator-activated receptors: a therapeutic target in COPD?Eur Respir J200831350250818310397
  • ShiHSchefflerJMPleitnerJMModulation of skeletal muscle fiber type by mitogen-activated protein kinase signalingFASEB J20082282990300018417546
  • LemireBBDebigareRDubéAThériaultMECoteCHMaltaisFMAPK signalling in the quadriceps of patients with chronic obstructive pulmonary diseaseJ Appl Physiol2012Epub April19
  • Riddoch-ContrerasJGeorgeTNatanekSAp38 mitogen-activated protein kinase is not activated in the quadriceps of patients with stable chronic obstructive pulmonary diseaseCOPD20129214215022409248
  • WilliamsAHLiuNvan RooijEOlsonENMicroRNA control of muscle development and diseaseCurr Opin Cell Biol200921346146919278845
  • ChenJFMandelEMThomsonJMThe role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiationNat Genet200638222823316380711
  • GüllerIRussellAPMicroRNAs in skeletal muscle: their role and regulation in development, disease and functionJ Physiol2010588Pt 214075408720724363
  • van RooijEQuiatDJohnsonBAA family of microRNAs encoded by myosin genes governs myosin expression and muscle performanceDev Cell200917566267319922871
  • McCarthyJJEsserKAPetersonCADupont-VersteegdenEEEvidence of MyomiR network regulation of beta-myosin heavy chain gene expression during skeletal muscle atrophyPhysiol Genomics200939321922619690046
  • LewisARiddoch-ContrerasJNatanekSADownregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPDThorax2012671263421998125
  • ClopAMarcqFTakedaHA mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheepNat Genet200638781381816751773
  • EliaLContuRQuintavalleMReciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditionsCirculation2009120232377238519933931
  • SunYGeYDrnevichJZhaoYBandMChenJMammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesisJ Cell Biol201018971157116920566686
  • LacasseYGoldsteinRLassersonTJMartinSPulmonary rehabilitation for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20064CD00379317054186
  • CasaburiRZuWallackRPulmonary rehabilitation for management of chronic obstructive pulmonary diseaseN Engl J Med2009360131329133519321869
  • O’DonnellDELamMWebbKAMeasurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981585 Pt 1155715659817708
  • MadorMJKufelTJPinedaLAEffect of pulmonary rehabilitation on quadriceps fatiguability during exerciseAm J Respir Crit Care Med2001163493093511282768
  • O’DonnellDEMcGuireMSamisLWebbKAGeneral exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitationAm J Respir Crit Care Med19981575 Pt 1148914979603128
  • ManWDKempPMoxhamJPolkeyMIExercise and muscle dysfunction in COPD: implications for pulmonary rehabilitationClin Sci (Lond)2009117828129119689433
  • CasaburiRPatessioAIoliFZanaboniSDonnerCFWassermanKReductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung diseaseAm Rev Respir Dis199114319181986689
  • MaltaisFLeBlancPJobinJIntensity of training and physiologic adaptation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199715525555619032194
  • van’t HulAGosselinkRHollanderPPostmusPKwakkelGTraining with inspiratory pressure support in patients with severe COPDEur Respir J2006271657216387937
  • SomfayAPórszászJLeeSMCasaburiREffect of hyperoxia on gas exchange and lactate kinetics following exercise onset in nonhypoxemic COPD patientsChest2002121239340011834648
  • PalangePValliGOnoratiPEffect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patientsJ Appl Physiol20049751637164215234959
  • VogiatzisIStrategies of muscle training in very severe COPD patientsEur Respir J201138497197521737548
  • Janaudis-FerreiraTHillKGoldsteinRWadellKBrooksDArm exercise training in patients with chronic obstructive pulmonary disease: a systematic reviewJ Cardiopulm Rehabil Prev200929527728319935139
  • GosselinkRDe VosJvan den HeuvelSPSegersJDecramerMKwakkelGImpact of inspiratory muscle training in patients with COPD: what is the evidence?Eur Respir J201137241642521282809
  • MaddocksMMurtonAJWilcockAImproving muscle mass and function in cachexia: non-drug approachesCurr Opin Support Palliat Care20115436136421934503
  • RoigMReidWDElectrical stimulation and peripheral muscle function in COPD: a systematic reviewRespir Med2009103448549519091537
  • VivodtzevIDebigaréRGagnonPFunctional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trialChest2012141371672522116795
  • AbdellaouiAPréfautCGouziFSkeletal muscle effects of electrostimulation after COPD exacerbation: a pilot studyEur Respir J201138478178821349913
  • GriffithsTLBurrMLCampbellIAResults at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trialLancet2000355920136236810665556
  • SteinerMCRoubenoffRTal-SingerRPolkeyMIProspects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: a translational reviewThorax2012Epub May5
  • RennardSIFogartyCKelsenSCOPD InvestigatorsThe safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007175992693417290043
  • YehSSDeGuzmanBKramerTM012 Study GroupReversal of COPD-associated weight loss using the anabolic agent oxandroloneChest2002122242142812171812
  • NagayaNItohTMurakamiSTreatment of cachexia with ghrelin in patients with COPDChest200512831187119316162705
  • NarayananRMohlerMLBohlCEMillerDDDaltonJTSelective androgen receptor modulators in preclinical and clinical developmentNucl Recept Signal20086e01019079612
  • SumukadasDWithamMDStruthersADMcMurdoMEEffect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trialCMAJ2007177886787417923654
  • DoorduinJSinderbyCABeckJThe calcium sensitizer levosimendan improves human diaphragm functionAm J Respir Crit Care Med20121851909521960535
  • AndeSRChenJMaddikaSThe ubiquitin pathway: an emerging drug target in cancer therapyEur J Pharmacol20096251–319920519835866
  • NarkarVADownesMYuRTAMPK and PPARdelta agonists are exercise mimeticsCell2008134340541518674809